Close
Help
Need Help?



5-Fluorouracil-Induced Chest Pain and ST-Segment Elevation

Submit a Paper


Libertas Analytics


2050 Article Views

Publication Date: 26 Mar 2008

Journal: Clinical Medicine Insights: Cardiology Clinical Medicine: Cardiology 2008:2 103-105

CMIcar
journal

112,119 Article Views

3,517,309 Libertas Article Views

More Statistics

Abstract Allison G. Dupont and Mauricio G. Cohen

Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Abstract

5-Fluorouracil (5-FU) is a chemotherapeutic agent commonly used to treat various malignancies. Cardiotoxicity is a rare adverse effect in patients being treated with 5-FU, but it can be severe and even fatal. The mechanism of myocardial ischemia caused by 5-FU is not known but several hypotheses exist, of which coronary vasospasm is the most widely accepted. Importantly, patients with preexisting coronary artery disease have been shown to be at increased risk of developing myocardial ischemia secondary to 5-FU. We present a case of 5-FU-induced chest pain and ST segment elevation in a patient with pre-existing coronary artery disease. The aim of this article is to provide a brief review of the available literature surrounding the topic of 5-FU cardiotoxicity and to heighten the readers’ awareness of the potential adverse cardiac effects of this agent.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES
Our Testimonials
My experience with Libertas Academica was great. The manuscript review, editing and publication process was easy and smooth and the support staff were great to work with.  Overall a great experience.
Assistant Professor Michael J Burke MD (University of Minnesota, Minneapolis, MN, USA) What our authors say